First-In-Class PreHistin Could Challenge Antihistamines In Two Years – Exec
This article was originally published in The Pink Sheet Daily
Executive Summary
Irvine, Calif.-based Cobalis, which has patent for using cyanocobalamin to treat Immunoglobulin E-mediated allergic diseases, expects NDA submission in Q3 2007.